Trading Halt
Filed with ASX · · 2 pages · English
On 6ix: 6ix.com/news/trading-halt-214
Trading in the securities of PYC Therapeutics Limited (‘PYC’) will be halted at the request of PYC, pending the release of an announcement by PYC. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of: • the commencement of normal trading on Wednesday, 4 February 2026; or • the release of the announcement to the market. PYC’s request for a trading halt is at
PYC Therapeutics Limited on 6ix
In the deck
Story so far
Earlier from PYC Therapeutics
- Quarterly Activities/Appendix 4C Cash Flow Report
- PKD Clinical Trial - Safety Outcomes in Part A
- Sustained Vision Improvement in RP11 Patients
- ADOA Program Initiation of Global Repeat Dose Study
- PMS Program Data Supports Progression to Human Trials
Later from PYC Therapeutics
- PYC Capital Raising Presentation
- PYC Raising up to $653m to Deliver Human Efficacy Data
- Completion of Placement and Institutional Entitlement Offer
- Retail Offer Booklet
- Half Yearly Report and Accounts
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics